National
-
Research-based pharmaceutical industry pledges 14 billion treatments to help end nine neglected tropical diseases
The research-based pharmaceutical industry announced donations of 14 billion treatments this decade to support the elimination or control of nine key neglected tropical diseases (NTDs). Averaging 1.4 billion treatments annually, the donations build upon companies’ existing medicines donation programs which already reach millions of people around the world.
National | 09 February 2012
-
US government HIV/AIDS clinical trial sites to accelerate completion of Phase III TB drug trial
The TB Alliance announces the launch of a collaboration with the National Institute of Allergy and Infectious Diseases’ (NIAID) AIDS Clinical Trial Group (ACTG) to conduct and help complete a Phase III clinical trial testing potentially faster-acting tuberculosis (TB) treatments.
National | 09 January 2012
-
APEC endorses principles for industry codes of ethics
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) welcomes the decision taken at the Asia-Pacific Economic Cooperation CEO Summit to endorse “The Mexico City Principles for Voluntary Codes of Business Ethics in the Biopharmaceutical Sector”, often referred to as the “Mexico City Principles”. These principles are fully aligned with the IFPMA’s global Code of Pharmaceutical Marketing Practices which sets standards for ethical promotion of medicines. The IFPMA looks forward to the Mexico City Principles being adopted by all industry sectors on a voluntary basis within all 21 APEC countries.
National | 16 November 2011
-
Launch of BioLynx provides a boost for the international malaria research community
New NUS spin-off company launches at TechVenture 2011.
National | 12 October 2011
-
BioAlliance Pharma presents orphan drug survival results at international liver cancer congress
BioAlliance Pharma SA announces oral communication of the phase 2 clinical trial results of its orphan product Livatag at the annual congress of ILCA (International Liver Cancer Association). Prof Philippe Merle, Professor of hepatology at the Hos…
National | 06 September 2011
-
Novartis International BioCamp spotlights diversity
Novartis has opened its eighth annual International Biotechnology Leadership Camp (BioCamp), a three-day seminar bringing biotechnology and business experts together with 60 selected students from leading international universities in 24 countries an…
National | 29 August 2011
-
Agilent Technologies and Chungnam National University collaborate to further glycomics research
Agilent Technologies Inc and Chungnam National University announced an agreement to develop new applications, methods, technologies and software tools in the field of glycomics, the study of complex sugars. The university aims to identify and deve…
National | 23 August 2011
-
Paromomycin added to national essential medicines list by government of Nepal
OneWorld Health (OWH) announced that its antibiotic paromomycin (PMIM) a life-saving medicine for the treatment of Kala-Azar (black fever), has been approved for the Essential Drug List of Nepal. This milestone signifies a major vote of confidence fr…
National | 17 August 2011
-
Pharmacyclics collaborates with National Cancer Institute to develop Btk inhibitor
Pharmacyclics, Inc announced the signing of a five-year cooperative research and development agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on the development of PCI-32765. This is a first-in-class, small molecule inhibitor…
National | 10 August 2011
-
INC Research completes acquisition of Kendle International
INC Research LLC announced it has completed the acquisition of Kendle International Inc in an all-cash transaction with a total equity value of approximately $232 million. The combined company will operate as INC Research LLC and will be led by James…
National | 13 July 2011
